From Research to Policy Implementation: Trastuzumab in Early-Stage Breast Cancer Treatment in Thailand
© 2018 Objectives: To evaluate the adjuvant therapy of trastuzumab cost and quality-adjusted life-years (QALYs) in lifetime horizon and describe the use of an economic evaluation in supporting policy-making decisions in the treatment of early-stage breast cancer in Thailand. Methods: A Markov model...
Saved in:
Main Authors: | Ronnachai Kongsakon, Surasit Lochid-amnuay, Nattiya Kapol, Oraluck Pattanaprateep |
---|---|
Other Authors: | Silpakorn University |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/50776 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Cost-utility analysis of home-based care for treatment of Thai hemophilia A and B
by: Oraluck Pattanaprateep, et al.
Published: (2018) -
Cost-utility analysis of drugs for secondary bone fracture prevention among post-menopausal osteoporotic patients in Thailand
by: Emika Wiroonpochit, et al.
Published: (2022) -
Hospitalization and cost after switching from atypical to typical antipsychotics in schizophrenia patients in Thailand
by: Tuanthon Boonlue, et al.
Published: (2018) -
Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines
by: Anne Julienne Genuino, et al.
Published: (2020) -
Safety and tolerability of docetaxel, cyclophosphamide, and trastuzumab compared to standard trastuzumab-based chemotherapy regimens for early-stage human epidermal growth factor receptor 2-positive breast cancer
by: Jitawatanarat,P., et al.
Published: (2015)